Treatment of glioblastoma in Greenlandic patients
ABSTRACTGlioblastoma (GBM), WHO grade IV, is the most common primary malignant brain tumour among adults with a devastating overall survival of 14–22 months. Standard treatment of GBM includes maximum safe resection, radiotherapy plus concomitant and adjuvant temozolomide (TMZ), given over a period...
Published in: | International Journal of Circumpolar Health |
---|---|
Main Authors: | , , , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Taylor & Francis Group
2023
|
Subjects: | |
Online Access: | https://doi.org/10.1080/22423982.2023.2285077 https://doaj.org/article/e4a1520eaa1747a3a180ecf3576ad7c6 |